Articles On Telix Pharmaceuticals (ASX:TLX)

Some ASX healthcare shares are going through a brutal period as competition, weaker demand and broader market pressures hammer investor confidence. CSL Ltd (ASX: CSL) has dominated headlines recently for all the wrong reasons, but other...

Presentations at specialist medical conferences along with publications in peer-reviewed journals offer important validation for ASX healthcare companies Alterity is presenting updates on ATH434, its Phase III-ready asset for MSA, at inter...

Highlights Mining stocks lifted market sentiment despite broader weakness Banking shares faced pressure ahead of the federal budget Copper rally pushed major resource companies higher The ASX 200 moved lower as investo...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin Weekly update on stockbroker recommendation, target price, and earnings forecast cha...

At the start of each week, I like to look at ASIC's short position report to find out which shares are being targeted by short sellers. This is because I believe it is well worth keeping a close eye on short interest levels as high levels...

Highlights Mining and banking shares weighed heavily on market sentiment. Geopolitical uncertainty kept investors cautious across sectors. Defensive sectors attracted attention amid broader market weakness. The ASX 200...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin The Australian market stumbled over the second half of April as inflation concerns r...

Gold has been one of the standout trades of the past year, and I can understand why investors have been drawn to it. When economic worries rise, geopolitical risks increase, and markets feel uncertain, gold often attracts attention. It c...

At the start of each week, I like to look at ASIC's short position report to find out which shares are being targeted by short sellers. This is because I believe it is well worth keeping a close eye on short interest levels as high levels...

Highlights Mining stocks lift broader market sentiment Lithium and rare earth shares regain traction Most sectors close in positive territory The Australian market staged a recovery led by strong momentum in resource s...

At The Bell — The April tailspin is worsening Down Under again, with the Australian share market now heading for a -0.7% drop that would solidify a seventh consecutive day of retreats and bring us to ~8,600 points. Listen to the HotCoppe...

The S&P/ASX 200 Index (ASX: XJO) has tumbled again in early morning trade on Wednesday as inflation fears, interest rate hike concerns, and surging oil prices continue to put pressure on Australian stocks across several sectors. Dur...

Highlights Telix emerges as the most shorted stock on the ASX, overtaking Domino’s Pizza 4DMedical records a sharp rise in bearish positioning amid valuation focus Several technology, travel, and resource stocks reflect shifting short...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin MELBOURNE, Australia and INDIANAPOLIS, April 28, 2026 /PRNewswire/ — Telix Pharma...

At the start of each week, I like to look at ASIC's short position report to find out which shares are being targeted by short sellers. This is because I believe it is well worth keeping a close eye on short interest levels as high levels...

It was a lacklustre finish to what has been a rather rough trading week for the S&P/ASX 200 Index (ASX: XJO) this Friday. After a shaky and volatile session that saw the index whipsaw quite a lot, the ASX 200 ended up closing 0.078% low...

Highlights Sharp sell-offs bring major names back into focus Short-term challenges contrast with long-term narratives Sector-specific factors driving recent volatility   Cochlear, Treasury Wine Estates, and Telix have faced recen...

It has been a rough period for a number of high-quality ASX 200 shares. Some have sold off heavily on short-term concerns, even though their longer-term outlooks still look intact. When that happens, I think it is worth taking a closer l...

Last week’s flurry of action at the radiopharmaceuticals leader Telix Pharmaceuticals (ASX:TLX) provided plenty of food for thought – and investors don’t know quite how to digest it. On the Monday, the stock surged up to 8.8% on news of a t...

Telix Pharmaceuticals Ltd (ASX: TLX) shares are all over the place. The ASX biotech stock is down 5% over the past five trading days, yet up 16% over the past month and 27% year to date. Zoom out further and the picture flips again. Teli...

Finding ASX shares that can genuinely scale over time is not always easy. A lot of companies talk about big opportunities, but only a handful actually build the foundations needed to turn that potential into long-term growth.  I th...

A gaggle of drug developers is due to disclose company-making clinical study results this year While late-stage clinical trial victory does not confer commercial success, the results tend to be ‘do or die’ In the main, share valuations don...

Telix Pharmaceuticals Ltd (ASX: TLX) shares are in the red in Tuesday lunchtime trade. At the time of writing the shares are down 1.7% to $14.50. Despite today's decline, the ASX biopharmaceutical company's shares have rebounded a whoppi...

Investors often target blue-chip ASX 200 shares for lower volatility and consistent earnings.  It's often assumed that because these companies are well-established, there is limited upside.  However, here are some blue-chip stocks th...

Telix Pharmaceuticals has lodged a cleansing notice with the ASX regarding its recently announced US$600 million convertible bond offering, a regulatory filing that clears the way for future share issuance without requiring a prospectus. Th...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin Australian biotechs are successfully turning promising science into a scalable, repe...

Highlights Short interest highlights shifting market sentiment Multiple ASX 200 names dominate the list Sector-wide concerns driving cautious positioning High short interest across ASX 200 stocks highlights cautious market sentime...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin Weekly update on stockbroker recommendation, target price, and earnings forecast cha...

At the start of each week, I like to look at ASIC's short position report to find out which shares are being targeted by short sellers. This is because I believe it is well worth keeping a close eye on short interest levels as high levels...

ASX health sector up 0.16% for the past five days while broader market rises 0.39% Pro Medicus signs $37 million renewal contract with US-based North Western Medicine  Consortium comprising Genesis Capital Investment Management and Washing...

Now could be a good time to buy Telix Pharmaceuticals Ltd (ASX: TLX) shares. That's the view of analysts at Bell Potter, who are tipping the radiopharmaceuticals company as a top buy this week. What is the broker saying? Bell Potter notes t...

Highlights Market rises on renewed US-Iran diplomacy optimism Tech stocks lead gains for second straight session Energy sector lags as oil prices ease ASX 200 opened higher on global optimism, with tech stocks leading gains while...

The S&P/ASX 200 Index (ASX: XJO) is having a relatively positive session on Wednesday. In afternoon trade, the benchmark index is up 0.1% to 8,982 points. Four ASX shares that have failed to follow the market higher today are listed b...

ASX consumer discretionary stocks have been largely underperforming in 2026. Rising interest rates, inflation and subdued consumer confidence have all weighed heavily on investor sentiment.  When economic headwinds like these hit at o...

Orthocell shares soar 20% after the go-ahead to sell flagship Remplir product to US defence and vet affairs hospitals Telix seals monster $840 million debt capital raising Forget Lego – Genetic Signatures finds its own Danish building bloc...

Telix Pharmaceuticals Ltd (ASX: TLX) shares are on the move on Wednesday morning. At the time of writing, the ASX radiopharmaceuticals stock is down 7.5% to $14.28. As a comparison, the ASX 200 index is trading 0.25% higher in morning trade...

The Virgin Australia Holdings Ltd (ASX: VGN) share price is in focus after the airline confirmed its FY26 financial guidance remains unchanged, with underlying EBIT and EBIT margin expected to improve in 2HFY26 despite a surge in fuel price...

The National Storage REIT (ASX: NSR) share price is in focus as investors digest news of the proposed $2.80-per-security cash offer from a Brookfield and GIC consortium, valuing the group at over $4 billion. Security holders who held NSR se...

The Evolution Mining Ltd (ASX: EVN) share price is in focus as the company moved to a net cash position in the March 2026 quarter, generating $406 million in group cash flow and maintaining strong operational delivery. Record quarterly net...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin MELBOURNE, Australia and INDIANAPOLIS, April 15, 2026 /PRNewswire/ – Telix Pharma...

The Telix Pharmaceuticals Ltd (ASX: TLX) share price is in focus today after the company successfully priced and increased its US$600 million convertible bond offering, up from US$550 million due to strong global investor demand. What did T...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin MELBOURNE, Australia and Indianapolis, April 15, 2026 /PRNewswire/ — Telix Pharma...

The Yancoal Australia Ltd (ASX: YAL) share price is in focus today following news that the company will acquire an 80% interest in the Kestrel Coal Mine, a large-scale, long-life metallurgical coal asset based in Queensland's Bowen Basin. K...

The Telix Pharmaceuticals Ltd (ASX: TLX) share price is in focus today after the company released an investor presentation, revealing strong top-line growth in 2025. Group revenue jumping 56% year-on-year to US$804 million, and underlying p...

On Tuesday, the S&P/ASX 200 Index (ASX: XJO) was on form and pushed higher. The benchmark index rose 0.5% to 8,970.8 points. Will the market be able to build on this on Wednesday? Here are five things to watch: ASX 200 to rise again T...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin MELBOURNE, Australia and INDIANAPOLIS, Ind., April 14, 2026 /PRNewswire/ — Telix...

Highlights Energy sector gains strength on oil supply concerns Tech and gold stocks weaken amid rising yields Company updates trigger sharp stock-specific moves The Australian market ended on a softer note as global te...

The S&P/ASX 200 Index (ASX: XJO) is having a reasonably poor start to the week. In afternoon trade, the benchmark index is down 0.45% to 8,921.3 points. Four ASX shares that are not letting that hold them back today are listed below. He...

Highlight Futures point to a softer start for the ASX 200 Oil surges as Strait of Hormuz tensions escalate Global markets turn cautious after last week’s rebound ASX 200 is set to open lower as Middle East tensions escalate, push...

Telix shares surge up to 9% after this morning’s surprise deal with Regeneron Relating to therapies not yet being developed by Telix, the compact includes a US$40 million upfront payment Oh baby! Genesis returns with improved Monash IVF o...